Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis ; volume:24 ; number:1 ; day:22 ; month:10 ; year:2024 ; pages:1-18 ; date:12.2024
BMC public health ; 24, Heft 1 (22.10.2024), 1-18, 12.2024
- Urheber
-
Ukwishaka, Joyeuse
Mela, Cyril Fotabong
Aseneh, Jerry Brown Njoh
Ettaj, Malak
Ilboudo, Dieudonné
Danwang, Celestin
Samadoulougou, Sekou
Kirakoya-Samadoulougou, Fati
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-024-20364-5
- URN
-
urn:nbn:de:101:1-2501102108359.951306644423
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ukwishaka, Joyeuse
- Mela, Cyril Fotabong
- Aseneh, Jerry Brown Njoh
- Ettaj, Malak
- Ilboudo, Dieudonné
- Danwang, Celestin
- Samadoulougou, Sekou
- Kirakoya-Samadoulougou, Fati
- SpringerLink (Online service)
Ähnliche Objekte (12)
Seroprevalence of SARS-CoV-2 antibodies in low-income university students
Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark
Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women
Seroprevalence of SARS-CoV-2 antibodies in Italy in newborn dried blood spots
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
Seroprevalence of SARS-CoV-2 antibodies in low-income university students
Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark
Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women
Seroprevalence of SARS-CoV-2 antibodies in Italy in newborn dried blood spots
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
Seroprevalence of SARS-CoV-2 antibodies in low-income university students
Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark
Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women
Seroprevalence of SARS-CoV-2 antibodies in Italy in newborn dried blood spots
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021